(WELL) Welltower - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US95040Q1040
Stock:
Total Rating 61
Risk 68
Buy Signal 0.37
| Risk 5d forecast | |
|---|---|
| Volatility | 20.2% |
| Relative Tail Risk | -0.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 33.23 |
| Character TTM | |
|---|---|
| Beta | 0.288 |
| Beta Downside | 0.607 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.99% |
| CAGR/Max DD | 3.50 |
EPS (Earnings per Share)
Revenue
Primary Risks
P/E ratio: 147.3944
Description: WELL Welltower
Welltower Inc. is a S&P 500 company, is positioned at the center of the silver economy, focusing on rental housing for aging seniors across the United States, United Kingdom and Canada. Our portfolio of 2,000+ seniors and wellness housing communities are positioned at the intersection of housing and hospitality, creating vibrant communities for mature renters and older adults. We believe our real estate portfolio is unmatched, located in highly attractive micro markets with stunning built environments. Yet, we are an unusual real estate organization as we view ourselves as an operating company in a real estate wrapper, driven by highly aligned partnerships and an unconventional culture. Through our disciplined approach to capital allocation powered by our Data Science platform and superior operating results driven by the Welltower Business System - our end-to-end operating platform - we aspire to deliver long-term compounding of per share growth for our existing investors, our North Star.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 936.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.08 > 1.0 |
| NWC/Revenue: 75.53% < 20% (prev 74.60%; Δ 0.92% < -1%) |
| CFO/TA 0.04 > 3% & CFO 2.88b > Net Income 936.8m |
| Net Debt (16.35b) to EBITDA (2.31b): 7.08 < 3 |
| Current Ratio: 5.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (710.2m) vs 12m ago 11.97% < -2% |
| Gross Margin: 39.18% > 18% (prev 0.38%; Δ 3879 % > 0.5%) |
| Asset Turnover: 18.03% > 50% (prev 15.39%; Δ 2.64% > 0%) |
| Interest Coverage Ratio: 0.26 > 6 (EBITDA TTM 2.31b / Interest Expense TTM 652.0m) |
Altman Z'' -0.02
| A: 0.12 (Total Current Assets 9.91b - Total Current Liabilities 1.86b) / Total Assets 67.30b |
| B: -0.14 (Retained Earnings -9.16b / Total Assets 67.30b) |
| C: 0.00 (EBIT TTM 171.9m / Avg Total Assets 59.17b) |
| D: -0.36 (Book Value of Equity -8.75b / Total Liabilities 24.10b) |
| Altman-Z'' Score: -0.02 = B |
Beneish M -2.84
| DSRI: 0.98 (Receivables 4.70b/3.52b, Revenue 10.67b/7.85b) |
| GMI: 0.98 (GM 39.18% / 38.50%) |
| AQI: 0.98 (AQ_t 0.82 / AQ_t-1 0.83) |
| SGI: 1.36 (Revenue 10.67b / 7.85b) |
| TATA: -0.03 (NI 936.8m - CFO 2.88b) / TA 67.30b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of WELL shares?
As of February 26, 2026, the stock is trading at USD 208.25 with a total of 1,430,481 shares traded.
Over the past week, the price has changed by +0.19%, over one month by +13.81%, over three months by +2.15% and over the past year by +39.52%.
Over the past week, the price has changed by +0.19%, over one month by +13.81%, over three months by +2.15% and over the past year by +39.52%.
Is WELL a buy, sell or hold?
Welltower has received a consensus analysts rating of 4.30.
Therefore, it is recommended to buy WELL.
- StrongBuy: 10
- Buy: 6
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WELL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 225.7 | 8.4% |
| Analysts Target Price | 225.7 | 8.4% |
WELL Fundamental Data Overview February 25, 2026
P/E Trailing = 147.3944
P/E Forward = 68.0272
P/S = 13.4747
P/B = 3.4664
P/EG = 3.6218
Revenue TTM = 10.67b USD
EBIT TTM = 171.9m USD
EBITDA TTM = 2.31b USD
Long Term Debt = 19.20b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 21.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.35b USD (from netDebt column, last quarter)
Enterprise Value = 162.39b USD (146.04b + Debt 21.38b - CCE 5.03b)
Interest Coverage Ratio = 0.26 (Ebit TTM 171.9m / Interest Expense TTM 652.0m)
EV/FCF = 57.02x (Enterprise Value 162.39b / FCF TTM 2.85b)
FCF Yield = 1.75% (FCF TTM 2.85b / Enterprise Value 162.39b)
FCF Margin = 26.70% (FCF TTM 2.85b / Revenue TTM 10.67b)
Net Margin = 8.78% (Net Income TTM 936.8m / Revenue TTM 10.67b)
Gross Margin = 39.18% ((Revenue TTM 10.67b - Cost of Revenue TTM 6.49b) / Revenue TTM)
Gross Margin QoQ = 38.30% (prev 39.99%)
Tobins Q-Ratio = 2.41 (Enterprise Value 162.39b / Total Assets 67.30b)
Interest Expense / Debt = 0.95% (Interest Expense 203.8m / Debt 21.38b)
Taxrate = 21.0% (US default 21%)
NOPAT = 135.8m (EBIT 171.9m * (1 - 21.00%))
Current Ratio = 5.34 (Total Current Assets 9.91b / Total Current Liabilities 1.86b)
Debt / Equity = 0.51 (Debt 21.38b / totalStockholderEquity, last quarter 42.13b)
Debt / EBITDA = 7.08 (Net Debt 16.35b / EBITDA 2.31b)
Debt / FCF = 5.74 (Net Debt 16.35b / FCF TTM 2.85b)
Total Stockholder Equity = 37.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.58% (Net Income 936.8m / Total Assets 67.30b)
RoE = 2.49% (Net Income TTM 936.8m / Total Stockholder Equity 37.69b)
RoCE = 0.30% (EBIT 171.9m / Capital Employed (Equity 37.69b + L.T.Debt 19.20b))
RoIC = 0.25% (NOPAT 135.8m / Invested Capital 54.62b)
WACC = 6.18% (E(146.04b)/V(167.42b) * Re(6.97%) + D(21.38b)/V(167.42b) * Rd(0.95%) * (1-Tc(0.21)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 13.39%
[DCF] Terminal Value 87.45% ; FCFF base≈2.59b ; Y1≈3.19b ; Y5≈5.44b
[DCF] Fair Price = 184.0 (EV 144.72b - Net Debt 16.35b = Equity 128.38b / Shares 697.8m; r=6.18% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 78.91 | EPS CAGR: 43.91% | SUE: 0.07 | # QB: 0
Revenue Correlation: 97.13 | Revenue CAGR: 24.22% | SUE: 3.22 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.50 | Chg7d=+0.500 | Chg30d=+0.500 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.46 | Chg7d=+0.280 | Chg30d=+0.280 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+26.1%
EPS next Year (2027-12-31): EPS=3.31 | Chg7d=+0.430 | Chg30d=+0.430 | Revisions Net=+1 | Growth EPS=+34.5% | Growth Revenue=+12.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 7.3% (Discount Rate 7.9% - Earnings Yield 0.7%)
[Growth] Growth Spread = +25.0% (Analyst 32.2% - Implied 7.3%)
P/E Forward = 68.0272
P/S = 13.4747
P/B = 3.4664
P/EG = 3.6218
Revenue TTM = 10.67b USD
EBIT TTM = 171.9m USD
EBITDA TTM = 2.31b USD
Long Term Debt = 19.20b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 21.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.35b USD (from netDebt column, last quarter)
Enterprise Value = 162.39b USD (146.04b + Debt 21.38b - CCE 5.03b)
Interest Coverage Ratio = 0.26 (Ebit TTM 171.9m / Interest Expense TTM 652.0m)
EV/FCF = 57.02x (Enterprise Value 162.39b / FCF TTM 2.85b)
FCF Yield = 1.75% (FCF TTM 2.85b / Enterprise Value 162.39b)
FCF Margin = 26.70% (FCF TTM 2.85b / Revenue TTM 10.67b)
Net Margin = 8.78% (Net Income TTM 936.8m / Revenue TTM 10.67b)
Gross Margin = 39.18% ((Revenue TTM 10.67b - Cost of Revenue TTM 6.49b) / Revenue TTM)
Gross Margin QoQ = 38.30% (prev 39.99%)
Tobins Q-Ratio = 2.41 (Enterprise Value 162.39b / Total Assets 67.30b)
Interest Expense / Debt = 0.95% (Interest Expense 203.8m / Debt 21.38b)
Taxrate = 21.0% (US default 21%)
NOPAT = 135.8m (EBIT 171.9m * (1 - 21.00%))
Current Ratio = 5.34 (Total Current Assets 9.91b / Total Current Liabilities 1.86b)
Debt / Equity = 0.51 (Debt 21.38b / totalStockholderEquity, last quarter 42.13b)
Debt / EBITDA = 7.08 (Net Debt 16.35b / EBITDA 2.31b)
Debt / FCF = 5.74 (Net Debt 16.35b / FCF TTM 2.85b)
Total Stockholder Equity = 37.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.58% (Net Income 936.8m / Total Assets 67.30b)
RoE = 2.49% (Net Income TTM 936.8m / Total Stockholder Equity 37.69b)
RoCE = 0.30% (EBIT 171.9m / Capital Employed (Equity 37.69b + L.T.Debt 19.20b))
RoIC = 0.25% (NOPAT 135.8m / Invested Capital 54.62b)
WACC = 6.18% (E(146.04b)/V(167.42b) * Re(6.97%) + D(21.38b)/V(167.42b) * Rd(0.95%) * (1-Tc(0.21)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 13.39%
[DCF] Terminal Value 87.45% ; FCFF base≈2.59b ; Y1≈3.19b ; Y5≈5.44b
[DCF] Fair Price = 184.0 (EV 144.72b - Net Debt 16.35b = Equity 128.38b / Shares 697.8m; r=6.18% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 78.91 | EPS CAGR: 43.91% | SUE: 0.07 | # QB: 0
Revenue Correlation: 97.13 | Revenue CAGR: 24.22% | SUE: 3.22 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.50 | Chg7d=+0.500 | Chg30d=+0.500 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.46 | Chg7d=+0.280 | Chg30d=+0.280 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+26.1%
EPS next Year (2027-12-31): EPS=3.31 | Chg7d=+0.430 | Chg30d=+0.430 | Revisions Net=+1 | Growth EPS=+34.5% | Growth Revenue=+12.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 7.3% (Discount Rate 7.9% - Earnings Yield 0.7%)
[Growth] Growth Spread = +25.0% (Analyst 32.2% - Implied 7.3%)